In our cohort, CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ T cells, and CD16+/ CD56+ NK cells showed significant differences in mild/moderate COVID-19 cases with and without progression. The gene discussed is CD19; the disease is COVID-19.